Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.00    1.80 (1.74%)
Bid:
103.80
Ask:
105.00
Spread: 1.20 (1.156%)
Market Cap: £172.14m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

1 May 2014 07:00

RNS Number : 0132G
Synthomer PLC
01 May 2014
Β 

ο»Ώ

1st May 2014

Β 

Synthomer plc

Β 

AGM and Interim Management Statement

Β 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 January to 30 April 2014.

Β 

Trading

Β 

We reported with our full year results in February that we had experienced slightly firmer demand in Europe across our Construction & Coatings, Functional Polymers and Performance Polymers segments. Encouragingly, this trend has continued, and as a result operating profit for the first quarter in our Europe and North America business (ENA) was ahead of the prior year, despite an adverse currency translation impact of Β£0.6M.

Β 

In our Asia and Rest of the World (ARW) business, volumes have continued to progress. However, recent substantial expansions by nitrile customers has led to excess glove capacity and aggressive competition between glove manufacturers. Combined with falling Butadiene prices this has resulted in destocking and short term pressure on nitrile margins. However, we expect on-going demand growth for nitrile latex and unit margins to firm as the year progresses.

Β 

The Group is currently developing plans for a further expansion of nitrile latex capacity, and expects to make an announcement in the next few months

Β 

Financial Position

Β 

Net debt increased over the first three months in line with normal seasonality. The Board has previously indicated it would move dividend cover to three times by 2015. However, in the light of the Group's current low leverage, and strong underlying cash flow generation, the Board is reviewing that policy with a view to increasing the planned level of returns to shareholders. Any revised dividend policy will be formally communicated to shareholders with the interim results.

Β 

Outlook

Whilst the start to the year in Europe has been encouraging, we remain cautious until these trends become more sustained. So far in 2014, Asia has performed below our expectations due to the competitive environment in the glove market. Although the overall Asia and ROW results may now be slightly weaker than our expectations at the start of the year, we believe the fundamental drivers for our business in the region remain strong.

Β 

The Board remains confident in the medium and long term outlook for the Group.

Β 

Synthomer will announce its Interim Results on Monday 11th August 2014.

Β 

Enquiries:

Β 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

The company will host a conference call for analysts at 8.00am (BST) today:

Β 

Dial-In: +44 203 426 2845Β 

Please quoteΒ "Synthomer" to gain access to the call

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSURAORSVASOUR
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.